Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mesenchymal stem cells in regenerative medicine: of hopes and challenges.

Literature DB >> 19295949

Mesenchymal stem cells in regenerative medicine: of hopes and challenges.

Claudius Conrad.

Abstract

Mesh：

Year: 2009 PMID： 19295949 PMCID： PMC2654701

Source DB: PubMed Journal: Medscape J Med ISSN： 1934-1997

Keyword Cloud
References

× No keyword cloud information.

8 in total

Review 1. Adult stem cell lines in regenerative medicine and reconstructive surgery.

Authors: Claudius Conrad; Ralf Huss
Journal: J Surg Res Date: 2005-04 Impact factor: 2.192

Review 2. Genetically engineered stem cells for therapeutic gene delivery.

Authors: Claudius Conrad; Rashmi Gupta; Hema Mohan; Hanno Niess; Christiane J Bruns; Reinhard Kopp; Irene von Luettichau; Markus Guba; Christopher Heeschen; Karl-Walter Jauch; Ralf Huss; Peter J Nelson
Journal: Curr Gene Ther Date: 2007-08 Impact factor: 4.391

Review 3. The systematic production of cells for cell therapies.

Authors: Daniel C Kirouac; Peter W Zandstra
Journal: Cell Stem Cell Date: 2008-10-09 Impact factor: 24.633

4. GATA transcription in a small rhodamine 123(low)CD34(+) subpopulation of a peripheral blood-derived CD34(-)CD105(+) mesenchymal cell line.

Authors: Claudius Conrad; Berthold Gottgens; Sarah Kinston; Joachim Ellwart; Ralf Huss
Journal: Exp Hematol Date: 2002-08 Impact factor: 3.084

5. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis.

Authors: Yulong He; Iiro Rajantie; Maritta Ilmonen; Taija Makinen; Marika J Karkkainen; Paula Haiko; Petri Salven; Kari Alitalo
Journal: Cancer Res Date: 2004-06-01 Impact factor: 12.701

Mesenchymal stem cells in regenerative medicine: of hopes and challenges.

Review 1. Adult stem cell lines in regenerative medicine and reconstructive surgery.

Review 2. Genetically engineered stem cells for therapeutic gene delivery.

Review 3. The systematic production of cells for cell therapies.

4. GATA transcription in a small rhodamine 123(low)CD34(+) subpopulation of a peripheral blood-derived CD34(-)CD105(+) mesenchymal cell line.

5. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis.

6. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.

Review 7. Tumour vascularization: sprouting angiogenesis and beyond.

Review 8. Engineering targeted viral vectors for gene therapy.